| Notes |
Gladstone Institutes
From Wikipedia, the free encyclopedia
Jump to navigationJump to search
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
This article contains content that is written like an advertisement. (March 2017)
A major contributor to this article appears to have a close connection with its subject. (July 2012)
Gladstone Institutes
UCSF Mission Bay (5815).JPG
Established 1979
President Deepak Srivastava
Faculty 30
Staff 450
Budget $80 million
Location 1650 Owens St., San Francisco, CA, San Francisco, California, United States
Coordinates 37°46′03″N 122°23′39″WCoordinates: 37°46′03″N 122°23′39″W
Website gladstoneinstitutes.org
Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease.[1] Its researchers study these diseases using techniques of basic and translational science.[2] Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.[3]
Founded in 1979, Gladstone is affiliated with the University of California, San Francisco (UCSF) and is located in San Francisco, adjacent to UCSF's Mission Bay campus. Approximately 450 staff members—including more than 300 scientists—work at Gladstone.[citation needed]
Contents
1 History
2 Research programs
2.1 Cardiovascular disease
2.2 Virology and immunology
2.3 Neurological disease
2.4 Stem cell technology
2.5 Translational research
3 Researchers
4 References
5 External links
History
Gladstone Institutes was founded in 1979 as a research and training facility housed at San Francisco General Hospital. Under the leadership of Robert Mahley[4]—a cardiovascular scientist recruited from the National Institutes of Health[5]—the institutes was launched with a $8 million trust from the late commercial real estate developer, J. David Gladstone.[6]
In 1991, the institutes expanded its focus to include virology and immunology in response to the growing HIV/AIDS crisis.[citation needed] In 1998 it founded a third institute dedicated to studying neurological diseases.[citation needed]
In 2004 the Gladstone Institutes moved to a new facility in San Francisco's Mission Bay, San Francisco neighborhood.[7] Two years later it founded a center dedicated to translating its biological discoveries into therapies.[citation needed] Three years later and together with Taube Philanthropies and the Koret Foundation, it founded the Taube-Koret Center for Huntington's Disease Research.[citation needed]
In 2010, Dr. Mahley stepped down in order to return to active research. R. Sanders "Sandy" Williams, Dean of the School of Medicine at Duke University, became Gladstone's new president.[8]
In 2011, the S.D. Bechtel, Jr. Foundation helped launch the Center for Comprehensive Alzheimer's Disease Research, while the Roddenberry Foundation helped launch the Roddenberry Stem Cell Center for Biology and Medicine.[3] Also in 2011, the independent and philanthropic Gladstone Foundation formed with the mission of expanding the financial resources for the institutes.[citation needed] |